Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Newly Diagnosed Type 1 Diabetes
NCT00730392Phase 2Completed
- Sponsor
- University at Buffalo
- Start
- Oct 2002
- Primary completion
- Oct 2007
- Modality
- Fc-Fusion Proteins
01
Overview
Phase 2, randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing Etanercept with Placebo (2 arms). Primary endpoints: Hemoglobin A1c at 24 weeks and C-peptide Area Under the Curve at 24 weeks. Started Oct 2002; status: completed.
02
Drugs
etanercept
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00730392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730392.